User Tools

Site Tools


ossification_of_the_posterior_longitudinal_ligament

Ossification of the posterior longitudinal ligament

Ossification of the posterior longitudinal ligament (OPLL) has been known as a multifactorial disease 1) 2).

Epidemiology

Ossification of the posterior longitudinal ligament (OPLL) in the cervical spine and related neurological complications are not uncommon in East Asian countries. The estimated prevalence of cervical OPLL-related hospitalization is 7.7 per 100,000 person-years in Taiwan, and higher incidence rates have been observed in elderly and male patients 3).

Etiology

Genetic factors are considered to play an important role in the etiology of OPLL based on nationwide pedigree surveys, twins surveys, and human leukocyte antigen (HLA) haplotype analysis 4).

The relationship between single-nucleotide polymorphisms (SNPs) in various genes and OPLL has been studied. A case-control association and sib-pair linkage studies have shown that several genes are related to the suscepti- bility to OPLL. These include genes for collagen, type VI, alpha 1 (COL6A1), collagen, type XI, alpha 2 (COL11A2), bone morphogenetic protein 2 (BMP2), ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), estrogen receptor 1 (ESR1), interleukin-1 beta (IL1B), leptin receptor, and transforming growth factor beta 1 (TGFB1) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14).

Clinical Features

The progression of cervical ossification of the posterior longitudinal ligament (OPLL) can lead to increase in the size of the OPLL mass and aggravation of neurological symptoms.

The most characteristic symptom of OPLL is myelopathy resulting from the compression of the spinal cord; other signs and symptoms include sensory dysfunction of the upper and the lower extremities, motor weakness, an in- creased deep tendon reflex, and neurogenic bladder and bowel 15). 16) 17).

Diagnosis

OPLL is not a two-dimensional (2D) disease, but rather a three-dimensional (3D) disease. Therefore, conventional measurement of parameters using radiography may not be suitable for evaluating OPLL.

3D method of measurement is superior to the conventional method in terms of evaluating the clinical state of symptomatic OPLL patients. Higher 3D OPLL ratio has an adverse effect on the spinal cord 18).

Treatment

There are multiple options for managing cervical OPLL, ranging from observation to many kinds of surgical procedures, including posterior laminoplasty, laminectomy with or without fusion, anterior corpectomy with or without instrumentation, and circumferential decompression and fusion. None of these surgical approaches is free of complications. However, to date, there is still a lack of consensus regarding the choice of the surgical approach and the timing of surgical intervention. Cervical SCI and related neurological disabilities are more likely to occur in OPLL patients, who should therefore be cautioned regarding the possibility of a subsequent SCI if treated without surgery 19).

Anterior cervical spine decompression and reconstruction is a safe and appropriate treatment for cervical myelopathy in the setting of single or two level OPLL. Cervical laminectomy or laminoplasty is indicated in patients with preserved cervical lordosis having three or more levels of involvement. Younger patients with good pre operative functional status and less than 2 levels of involvement have better outcome following anterior surgery 20).

Outcome

Case series

A retrospective study included patients (662 males and 251 females; mean age 55.8 years) with symptomatic OPLL. All patients had been diagnosed with OPLL based on cervical magnetic resonance imaging and computed tomography scans. Demographic, surgical outcome was measured using visual analog scale (VAS) and Japanese Orthopedic Association (JOA) scale scores. The results of our study indicated radicular pain was more common in segmental and circumscribe OPLL subtypes (P < 0.05). An anterior approach was favored in patients with less than 3 involved vertebral levels (P < 0.05). All surgical methods showed good outcomes (P < 0.05). Continuous and mixed OPLL subtypes showed worse surgical outcome with higher VAS and JOA scores (P < 0.05). Laminoplasty and anterior cervical discectomy and fusion were significantly associated with a higher recovery rate (P < 0.05). Among these patients, there were more complications with the anterior approach (P < 0.05). Male gender, open door laminoplasty ipsilateral, and ipsilateral-to-symptom-side opening were associated with postoperative C5 palsy (P < 0.05). Cervical OPLL may cause myelopathy, surgery is a safe and effective treatment for OPLL. There were no differences in clinical outcome according to surgical type, but complication rates varied depending on sex and surgical approach to symptom 21).


Moon et al., from the Departement of Neurosurgery, Chonnam National University Hospital and Medical School, Gwangju, Korea. examined the prevalence and incidence of cervical OPLL. Age/sex-matched controls were randomly extracted, with 10 times the number of OPLL cases. The differences in sex, co-morbidity, and relative survival rate, compared with controls, were assessed.

The cumulative prevalence was 20,960 per 1,025,340 people for 12 years. The annual incidence was approximately 199 to 371 per 1 million people. Overall, the crude mortality rate was 7.64%. The relative survival rate of OPLL cases was not significantly different from that of control cases. Diabetes, hypertension, cardiovascular disease, and cerebrovascular disease, except renal disease, correlated significantly with OPLL, compared with controls (p < 0.001). Additionally, between dead and surviving patients among the OPLL cases, all co-morbidities correlated more significantly with death (p < 0.001). Further, between the surgery and non-surgery cases of OPLL, diabetes, hypertension, and renal disease (p < 0.05) were significantly associated with surgery.

The annual incidences of OPLL were from 199 to 371 per 1,025,340 people for 10 years. Diabetes, hypertension, cardiovascular disease, and cerebrovascular disease, except renal disease, correlated significantly with OPLL, compared with controls. Especially, diabetes, hypertension, and renal disease were associated with OPLL patients who underwent surgery 22).


Sixty patients with cervical OPLL were included. All underwent an initial CT examination and had at least 24 months' follow-up with CT. The mean duration of follow-up was 29.6 months. Fourteen patients (Group A) had CT evidence of OPLL progression, and 46 (Group B) did not show evidence of progression on CT. The 2 groups were compared with respect to the following variables: sex, age, number of involved segments, type of OPLL, and treatment methods. The CT findings, such as the connection of an OPLL mass with the vertebral body and formation of trabeculation in the mass, were evaluated.

Sex and treatment modality were not associated with OPLL progression. The mean age of the patients in Group A was significantly lower than that in Group B (p = 0.03). The mean number of involved segments was 5.3 in Group A and 3.6 in Group B (p = 0.002). Group A had a higher proportion of cases with the mixed type of OPLL, whereas Group B had a higher proportion of cases with the segmental type (p = 0.02). A connection between the vertebral body and OPLL mass and trabeculation formation were more common in Group B (p < 0.01).

Progression of cervical OPLL is associated with younger age, involvement of multiple levels, and mixed-type morphology. OPLL masses that are contiguous with the vertebral body and have trabecular formation are useful findings for identifying masses that are less likely to progress 23).

1)
Inamasu J, Guiot BH, Sachs DC. Ossification of the posterior longitudinal ligament: an update on its biol- ogy, epidemiology, and natural history. Neurosurgery 2006;58:1027-39.
2) , 4)
Matsunaga S, Yamaguchi M, Hayashi K, Sakou T. Genetic analysis of ossification of the posterior longitu- dinal ligament. Spine (Phila Pa 1976) 1999;24:937-8.
3) , 19)
Wu JC, Chen YC, Huang WC. Ossification of the Posterior Longitudinal Ligament in Cervical Spine: Prevalence, Management, and Prognosis. Neurospine. 2018 Mar;15(1):33-41. doi: 10.14245/ns.1836084.042. Epub 2018 Mar 28. Review. PubMed PMID: 29656627.
5)
KongQ,MaX,LiF,GuoZ,QiQ,LiW,etal.COL6A1poly- morphisms associated with ossification of the liga- mentum flavum and ossification of the posterior longi- tudinal ligament. Spine (Phila Pa 1976) 2007;32:2834-8.
6)
Koga H, Hayashi K, Taketomi E, Matsunaga S, Yas- hiki S, Fujiyoshi T, et al. Restriction fragment length polymorphism of genes of the alpha 2(XI) collagen, bone morphogenetic protein-2, alkaline phosphatase, and tumor necrosis factor-alpha among patients with ossification of posterior longitudinal ligament and controls from the Japanese population. Spine (Phila Pa 1976) 1996;21:469-73.
7)
Maeda S, Koga H, Matsunaga S, Numasawa T, IkariK, Furushima K, et al. Gender-specific haplotype as- sociation of collagen alpha2 (XI) gene in ossification of the posterior longitudinal ligament of the spine. J Hum Genet 2001;46:1-4.
8)
Maeda S, Ishidou Y, Koga H, Taketomi E, Ikari K, Komiya S, et al. Functional impact of human collagen alpha2(XI) gene polymorphism in pathogenesis of os- sification of the posterior longitudinal ligament of the spine. J Bone Miner Res 2001;16:948-57.
9)
Horikoshi T, Maeda K, Kawaguchi Y, Chiba K, Mori K, Koshizuka Y, et al. A large-scale genetic association study of ossification of the posterior longitudinal liga- ment of the spine. Hum Genet 2006;119:611-6. ((Furushima K, Shimo-Onoda K, Maeda S, Nobukuni T, Ikari K, Koga H, et al. Large-scale screening for candi- date genes of ossification of the posterior longitudinal ligament of the spine. J Bone Miner Res 2002;17:128-37.
10)
Nakamura I, Ikegawa S, Okawa A, Okuda S, Koshizuka Y, Kawaguchi H, et al. Association of the human NPPS gene with ossification of the posterior longitudinal liga- ment of the spine (OPLL). Hum Genet 1999;104:492-7.
11)
Koshizuka Y, Kawaguchi H, Ogata N, Ikeda T, Mabuchi A, Seichi A, et al. Nucleotide pyrophosphatase gene polymorphism associated with ossification of the pos- terior longitudinal ligament of the spine. J Bone Miner Res 2002;17:138-44.
12)
Ogata N, Koshizuka Y, Miura T, Iwasaki M, Hosoi T, Shiraki M, et al. Association of bone metabolism regu- latory factor gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity. Spine (Phila Pa 1976) 2002;27:1765-71.
13)
Tahara M, Aiba A, Yamazaki M, Ikeda Y, Goto S, Mori- ya H, et al. The extent of ossification of posterior lon- gitudinal ligament of the spine associated with nucle- otide pyrophosphatase gene and leptin receptor gene polymorphisms. Spine (Phila Pa 1976) 2005;30:877-80.
14)
Kawaguchi Y, Furushima K, Sugimori K, Inoue I, Ki- mura T. Association between polymorphism of the transforming growth factor-beta1 gene with the ra- diologic characteristic and ossification of the poste- rior longitudinal ligament. Spine (Phila Pa 1976) 2003; 28:1424-6.
15)
Mizuno J, Nakagawa H. Ossified posterior longitudinal ligament : management strategies and outcomes. Spine J 2006;6(6 Suppl):282S-288S.
16)
Koga H, Sakou T, Taketomi E, Hayashi K, Numasawa T, Harata S, et al. Genetic mapping of ossification of the posterior longitudinal ligament of the spine. Am J Hum Genet 1998;62:1460-7.
17)
Sakou T, Taketomi E, Matsunaga S, Yamaguchi M, So- noda S, Yashiki S. Genetic study of ossification of the posterior longitudinal ligament in the cervical spine with human leukocyte antigen haplotype. Spine (Phila Pa 1976) 1991;16:1249-52.
18)
Lee N, Yeul Ji G, Shin HC, Ha Y, Jang JW, Shin DA. Usefulness of three-dimensional measurement of ossification of the posterior longitudinal ligament (OPLL) in patients with OPLL-induced myelopathy. Spine (Phila Pa 1976). 2015 Jul 22. [Epub ahead of print] PubMed PMID: 26208225.
20)
Kommu R, Sahu BP, Purohit AK. Surgical outcome in patients with cervical ossified posterior longitudinal ligament: A single institutional experience. Asian J Neurosurg. 2014 Oct-Dec;9(4):196-202. doi: 10.4103/1793-5482.146602. PubMed PMID: 25685216; PubMed Central PMCID: PMC4323963.
21)
Yudoyono F, Cho PG, Park SH, Moon BJ, Yi S, Ha Y, Kim KN, Yoon DH, Shin DA. Factors associated with surgical outcomes of cervical ossification of the posterior longitudinal ligament. Medicine (Baltimore). 2018 Jul;97(29):e11342. doi: 10.1097/MD.0000000000011342. PubMed PMID: 30024507.
22)
Moon BJ, Choi SK, Shin DA, Yi S, Kim KN, Yoon DH, Ha Y. Prevalence, Incidence, Co-morbidity, and Mortality Rates of Ossification of Posterior Longitudinal Ligament (OPLL) in the Cervical Spine: A Nested Case-Control Cohort Study. World Neurosurg. 2018 Jun 12. pii: S1878-8750(18)31238-5. doi: 10.1016/j.wneu.2018.06.023. [Epub ahead of print] PubMed PMID: 29906583.
23)
Choi BW, Baek DH, Sheffler LC, Chang H. Analysis of progression of cervical OPLL using computerized tomography: typical sign of maturation of OPLL mass. J Neurosurg Spine. 2015 Jul 17:1-5. [Epub ahead of print] PubMed PMID: 26186351.
ossification_of_the_posterior_longitudinal_ligament.txt · Last modified: 2018/07/20 17:07 by administrador